|About the Book|
ALZHEIMER’S: MY JOURNEY TO A NEXT GENERATION TREATMENT is the true story of the discovery and potential waste of a powerful advanced treatment for Alzheimer’s dementia. This gut-wrenching adventure is an exposé of how a major new hope for Alzheimer’s disease may be lost forever. A weekend experiment with a bizarre chemical out of an old lab freezer by the author as a graduate student leads to the discovery that methanesulfonyl fluoride (MSF) could revolutionize Alzheimer’s treatment. The author struggles alone to build a primitive lab and bring MSF, a simple and inexpensive drug, to the Alzheimer’s community. This forty-year odyssey of overcoming some self-inflicted setbacks, bumbling university administrators, and incompetent patent attorneys, eventually takes the author to Argentina and Mexico to find a way to prove that MSF can relieve the suffering of Alzheimer’s patients. This story, sprinkled with ambition, torment, and humor, will give readers a unique insight into how scientists work, the desperation of Alzheimer’s patients, and the strength of the human spirit. It also contrasts the warmth of human kindness and the support of colleagues with the cruel reality of how the survival of an innovative next generation treatment can be threatened simply because it was born out of the wedlock of Big Money and Big Pharma.Dr. Donald E. Moss received his Bachelor of Science degree in psychology at Colorado State University in 1966. After two years in the U.S. Army as a field artillery officer, including a year in Korea, he returned to Colorado State University and received his Ph.D. in Physiological Psychology in 1973. He completed a two-year Sloan Foundation Postdoctoral Fellowship in the Neurosciences at the University of California at San Diego in 1975. He left San Diego to take a faculty position at the University of Texas at El Paso. He retired his faculty position to devote full time to the development of MSF. Dr. Moss has published over 100 articles, chapters and abstracts on various topics related to brain research, most of them focused on the development of MSF for Alzheimers dementia. His work has appeared in highly respected medical journals including Brain Research, Nature, Alzheimers Disease and Related Disorders, Journal of Pharmacology and Experimental Therapeutics, and Neurobiology of Aging. He has also served on the Editorial Board of Neurobiology of Aging. The Governor of Texas, W.P. Clements, appointed Dr. Moss to two terms on the Texas Council on Alzheimers Disease and Related Disorders. He has also won numerous awards including the University of Texas at El Paso Award for Excellence in Research (1991) and the University of Texas at El Paso Award for Excellence in Teaching (1996), making him one of the few faculty members to win university awards for both teaching and research. Dr. Moss is a nationally and internationally recognized expert on acetylcholinesterse inhibitors and their use in the facilitation of memory, especially in aging and Alzheimers disease. He has spoken on Alzheimers disease and its treatment at many national and international conferences.